17.11.26

As Session Chair at ISRG 2026, Dr. Wiwat shares perspectives on the evolving landscape of reproductive medicine and embryo genetics.

As Session Chair at ISRG 2026, Dr. Wiwat shares perspectives on the evolving landscape of reproductive medicine and embryo genetics.

SAFE Fertility Group PCL Founder and CEO, Wiwat Quangkananurug, M.D., was invited to serve as a Session Chair at the 2026 Annual Conference of the International Society of Reproductive Genetics (ISRG 2026). The prestigious international gathering took place from November 15 to 17, 2026, at the Grande Centre Point Lumphini in Bangkok, Thailand.

Operating under the theme “Advancing Reproductive Genetics: Innovation and Global Collaboration,” ISRG 2026 brought together leading fertility specialists from global institutions to drive scientific discovery and translate cutting-edge research into clinical practice. The conference highlighted vital breakthroughs across preimplantation genetic testing (PGT-A and PGT-M), non-invasive prenatal testing (NIPT), single-cell genomics, and the genetic underpinnings of infertility and reproductive disorders.

On November 17, 2026, Dr. Wiwat presided over Session 5, the Morning Plenary. This prominent session featured keynote lectures from internationally recognized professionals in reproductive medicine. As Chair, Dr. Wiwat had the honor of introducing and facilitating discussions with the following distinguished speakers:

  • Prof. Luca Gianaroli from the Interdisciplinary Institute of Reproductive Medicine in Bologna, Italy, who delivered an insightful remote video presentation titled, "The role of PGT in the ART paradigm shift.”
  • Dr. Catherine Racowsky, Professor Emerita at Harvard Medical School, USA, who presented on "Genetics and reproductive medicine: Where are we going?" and shared her extensive experience regarding the molecular mechanisms of the oocyte and methodologies for assessing human embryo developmental competence.
  • Prof. Johan Smitz from the Vrije Universiteit Brussel (VUB), Belgium, who presented "In vitro maturation models: its science and clinical progress," highlighting his renowned work in reproductive medicine, endocrine physiology, and follicle biology.

Being selected to chair a plenary session among such distinguished global speakers underscores Dr. Wiwat’s dedication to the continuous advancement of reproductive technologies. It also reflects SAFE Fertility Group’s ongoing mission to foster international cooperation, elevate clinical standards, and bring highly advanced, reliable fertility care to families worldwide.